Effectiveness of electromyography guided botulinum toxin injection and dextrose prolotherapy in recurrent TMJ dislocation (radiographic and clinical study)

Moataz Soliman Moussa; Mohsen Fawzy Abo Elhasan; Abdel Aziz Baiomy Abdullah

doi:10.53730/ijhs.v6nS6.11501

Authors

Moataz Soliman Moussa BDS, 2009G MSc, 2018G, Faculty of Dental medicine, Al-Azhar University (Cairo, Boys)
Mohsen Fawzy Abo Elhasan Department of Oral and Maxillofacial Surgery, Faculty of Dental Medicine, Al-Azhar University, Assuit, Egypt
Abdel Aziz Baiomy Abdullah
abdelazizbaiomy@azhar.edu.eg
Department of Oral and Maxillofacial Surgery, Faculty of Dental Medicine, Al-Azhar University, Assuit, Egypt

Keywords:

EMG guided injection, TMJ dislocation, botulinum toxin type A, dextrose, visual analogue scale

Abstract

Objectives: This study was conducted to assess effectiveness of dextrose prolotherapy, Electromyography (EMG) Guided Botulinum Toxin – A (BTX-A) Injection, and combination between them in treatment of recurrent TMJ Dislocation cases. Subjects and methods: This current study was carried out on 60 adult patients suffering from recurrent TMJ Dislocation. The patients divided equally into three groups, Group I: 20 patients were treated with EMG guided BTX-A injection. Group II: 20 patients were treated with dextrose prolotherapy. Group III: 20 patients were treated with combination of EMG guided BTX-A injection and dextrose prolotherapy. The clinical evaluation preoperatively and postoperatively (at 1week , 3 months , 6 months) included visual analog scale of TMJ pain, maximum mouth opening (MMO), and frequency of luxations . Radiographic evaluation using MRI was done preoperatively, and at 6 months. The collected data were then statistically analyzed. Results: best results were recorded in group III compared with other groups; at all intervals of study with significant reduction of pain score, and frequency of luxations beside to improvement of MMO measurements. Conclusion: the combination of EMG guided BTX-A injection and dextrose prolotherapy is a promising treatment in recurrent TMJ dislocation cases.

Downloads

Download data is not yet available.

References

Torres DE, McCain JP. Arthroscopic electrothermal capsulorrhaphy for the treatment of recurrent temporomandibular joint dislocation. Int J Oral Maxillofac Surg. 2012;41(6):681-9.

Leopard PJ. Surgery of the non-ankylosed temporomandibular joint. Br J Oral Maxillofac Surg 1987; 25: 138-48.

Sinclair CF, Gurey LE, Blitzer A.Oromandibular dystonia: long-term management with botulinum toxin. Laryngoscope 2013; 123: 3078-83.

Baur DA, Jannuzzi JR, Mercan U, Quereshy FA. Treatment of long term anterior dislocation of the TMJ. Int J Oral Maxillofac Surg. 2013;42(8):1030-3.

Martínez-Pérez D, García Ruiz-Espiga P. Recurrent temporomandibular joint dislocation treated with botulinum toxin: report of 3 cases. J Oral Maxillofac Surg 2004; 62: 244-6.

Vasquez Bouso O, Forteza Gonzalez G, Mommsen J, et al. Neurogenic temporomandibular joint dislocation treatment with botulinum toxin: report of 4 cases. Oral Surg Oral Med Oral Pathol Oral Radiol Endod. 2010;109: 33–7.

Kahn et al. Assessing the effectiveness of botulinum toxin injections into masticatory muscles in the treatment of temporomandibular disorders. J Oral Med Oral Surg 2018;24:107-11.

Hakala R V. Prolotherapy (proliferation therapy) in the treatment of TMD. Craniomandibular Practice. 2005;23(4):283- 8.

Nitzan D.W., Dolwick M.F., Martinez G.A.: Temporomandibular Joint Arthrocentesis: A Simplified Treatment for Severe, Limited Mouth Opening. J Oral Maxillofac Surg 1991; 49:1163-7.

8. Dionne R.A.: Pharmacologic Treatments of Temporomandibular Disorders. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 1997; 83:134-142.

Stein C., Comisel K., Hainerl E.: Analgesic Effect of Intra-ArticularMorphine after Arthroscopic Knee Surgery. New Engl J Med 1991; 325:1123-6.

Mubashir Younis, Ajaz A. Shah, Abina Rashid. Evaluating the effect of dextrose prolotherapy on temporomandibular disorders by choosing different injection sitesa comparative clinical study. International Journal of Contemporary Medical Research 2020;7(1):A1-A3

Fouda AA. Change of site of intra-articular injection of hypertonic dextrose resulted in different effects of treatment. Br J Oral Maxillofac Surg 2018; 56(8):715-718

Antczak-Bouckoms A. Epidemiology of research for temporomandibular disorders. J Orofac Pain 1995; 9: 226–34.

Stein C., Hassan A.H., Lehrberger K., Giefling J., YassouridisA.: Local Analgesic Effects of Endogenous Opioid Peptides. Lancet 1993; 342:32-4.

14.Cömert Kiliç S, Güngörmüş M. Is dextrose prolotherapy superior to placebo for the treatment of temporomandibular joint hypermobility? A randomized clinical trial. Int J Oral Maxillofac Surg. 2016;45(7):813819

Zhou H, Hu K, Ding Y. Modified dextrose prolotherapy for recurrent temporomandibular joint dislocation. Br J Oral Maxillofac Surg. 2014;52(1):63-6.

Karacalar A ; Yįlmaz N, Bilgici A ; Baş B; Akan H. Botulinum toxin for the treatment of temporomandibular joint disk disfigurement: clinical experience . J. of Craniofac Surg: 2005, 16 (3): 476-81

Martínez Pérez D, García Ruiz Espiga P. Recurrent temporomandibular joint dislocation treated with botulinum toxin: Report of 3 cases. J Oral Maxillofac Surg 2004;62:244 6..

Refai H, Altahhan O, Elsharkawy R. The efficacy of dextrose prolotherapy for temporomandibular joint hypermobility: a preliminary prospective, randomized, double-blind, placebo-controlled clinical trial. J Oral Maxillofac Surg. 2011;69(12):2962-70

Nyandra, M., Kartiko, B.H., Susanto, P.C., Supriyati, A., Suryasa, W. (2018). Education and training improve quality of life and decrease depression score in elderly population. Eurasian Journal of Analytical Chemistry, 13(2), 371-377.

Dwijayanti, N., Mufdlilah, M., & Suryaningsih, E. K. (2022). The role of midwives in the application of classroom services for pregnant women during the COVID-19 pandemic period. International Journal of Health & Medical Sciences, 5(3), 228-239. https://doi.org/10.21744/ijhms.v5n3.1918